ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
2,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
3,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
3,4,Respiratory tract congestion,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
4,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
5,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
5,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,5,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
5,7,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
5,9,Urinary tract stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
6,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,3,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
6,4,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,5,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,6,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,7,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,8,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,9,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
6,12,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,13,Glucose urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,14,Headache,Headaches NEC,Headaches,Nerv,N
6,15,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
6,16,Micturition frequency decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,17,Nitrite urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,18,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
6,19,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,20,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,21,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,22,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
6,23,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
6,24,White blood cells urine positive,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
7,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,3,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
7,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
7,5,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,7,Colorectal cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
7,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
7,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,12,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,14,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
7,15,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7,16,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
7,17,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
7,18,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,19,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,21,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
7,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
8,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
10,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
10,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
12,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
13,1,Metastases to larynx,Metastases to specified sites,Metastases,Neopl,N
14,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
15,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
16,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
16,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
17,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
17,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
17,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
18,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
19,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
20,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
20,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
20,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,5,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
20,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
20,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,8,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
20,10,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
20,11,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
21,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
22,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
22,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
22,6,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
23,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
23,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
24,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
24,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
24,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
25,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
26,2,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
26,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
26,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
26,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
26,6,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
26,7,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
27,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
28,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,1,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
31,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
32,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
34,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
34,2,Osteosarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
35,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
35,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
36,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
36,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
37,2,Osteosarcoma metastatic,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
38,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
38,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
39,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
40,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
41,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
41,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
41,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
42,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
42,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
43,1,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
43,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
43,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
44,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
45,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
46,1,Anal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
47,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
48,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
48,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
49,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
49,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
50,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
50,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
52,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
52,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
